Onsior is a drug owned by ELANCO US INC. It is protected by 2 US drug patents filed from 2018 to 2021. All patents have expired. Details of Onsior’s patents and their expiration are given below.
| Drug Patent Number | Drug Patent Expiry | Status |
|---|---|---|
 | ||
| US6310099 | 25 Aug, 2018 | Expired |
Exclusivity Information
Onsior holds 1 exclusivity out of which 1 has expired. Details of Onsior's exclusivity codes and their expiration dates are given below.
| Drug Exclusivity | Drug Exclusivity Expiration |
|---|---|
| NCI | May 17, 2019 |
Onsior Petitions
Details of Onsior's suitability petitions are listed below.
| Petitioner | Action | Date of Action | Description |
|---|---|---|---|
 | |||
| Ray Law Firm, PLLC | Approved | NA | |
About Onsior
Onsior is a drug
owned by ELANCO US INC.
Onsior uses
Robenacoxib as the active
ingredient.
Active Ingredient:
Onsior uses
Robenacoxib as the active ingredient.
Check out other Drugs and Companies using
Robenacoxib ingredient.